Anbio Biotechnology (NASDAQ:NNNN) Stock Price Up 8.2% – Should You Buy?

Shares of Anbio Biotechnology (NASDAQ:NNNN) traded up 8.2% during mid-day trading on Thursday . The company traded as high as $15.80 and last traded at $16.5070. Approximately 20,983 shares traded hands during mid-day trading, a decline of 52% from the average daily volume of 43,304 shares. The stock had previously closed at $15.25.

Analysts Set New Price Targets

Separately, Weiss Ratings raised Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, May 14th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company has an average rating of “Hold”.

Anbio Biotechnology Stock Up 1.1%

The stock’s 50 day simple moving average is $25.40.

Anbio Biotechnology (NASDAQ:NNNN) last released its quarterly earnings data on Tuesday, April 7th. The company reported $0.03 earnings per share (EPS) for the quarter.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.